Íomhá chlúdaigh

Inhalable ciprofloxacin/polymyxin B dry powders in respiratory infection therapy

The current study focused on the formulation, physicochemical characterization, and antibacterial susceptibility testing of inhalable spray dried powders containing ciprofloxacin (CIP) and polymyxin B sulfate (PMB). CIP nanosuspensions with an average particle diameter of 435.9 ± 9.3 nm were initial...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Zhengqi Xu (Údar), Hriday Bera (Údar), Hengzhuang Wang (Údar), Junwei Wang (Údar), Dongmei Cun (Údar), Yu Feng (Údar), Mingshi Yang (Údar)
Formáid:	LEABHAR
Foilsithe / Cruthaithe:	Compuscript Ltd, 2023-04-01T00:00:00Z.
Ábhair:	article
Rochtain ar líne:	Connect to this object online.
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
de réir: Yi Guo, et al.
Foilsithe / Cruthaithe: (2021)

Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infections: A Drug Pair Limiting the Development of Resistance
de réir: Junwei Wang, et al.
Foilsithe / Cruthaithe: (2023)

In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release Formulations
de réir: Changzhi Shi, et al.
Foilsithe / Cruthaithe: (2023)

The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
de réir: Edit Benke, et al.
Foilsithe / Cruthaithe: (2021)

Mannose-Decorated Solid-Lipid Nanoparticles for Alveolar Macrophage Targeted Delivery of Rifampicin
de réir: Hriday Bera, et al.
Foilsithe / Cruthaithe: (2024)

Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions
de réir: Mohammad Zaidur Rahman Sabuj, et al.
Foilsithe / Cruthaithe: (2022)

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
de réir: Karimi K, et al.
Foilsithe / Cruthaithe: (2016)

Delivery of theophylline as dry powder for inhalation
de réir: Bing Zhu, et al.
Foilsithe / Cruthaithe: (2015)

Studies on the spray dried lactose as carrier for dry powder inhalation
de réir: Linna Wu, et al.
Foilsithe / Cruthaithe: (2014)

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
de réir: Priya Muralidharan, et al.
Foilsithe / Cruthaithe: (2014)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
de réir: Kimberly B. Shepard, et al.
Foilsithe / Cruthaithe: (2022)

Understanding the Importance of Capsules in Dry Powder Inhalers
de réir: Francesca Buttini, et al.
Foilsithe / Cruthaithe: (2021)

Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements
de réir: Sabrina Magramane, et al.
Foilsithe / Cruthaithe: (2023)

Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis
de réir: Peng Lu, et al.
Foilsithe / Cruthaithe: (2022)

Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
de réir: Tushar Saha, et al.
Foilsithe / Cruthaithe: (2022)

Influence of physical properties of carrier on the performance of dry powder inhalers
de réir: Tingting Peng, et al.
Foilsithe / Cruthaithe: (2016)

The influence of amino acids on aztreonam spray-dried powders for inhalation
de réir: Xiao-Fei Yang, et al.
Foilsithe / Cruthaithe: (2015)

Lactose Engineering for Better Performance in Dry Powder Inhalers
de réir: Yahya Rahimpour, et al.
Foilsithe / Cruthaithe: (2012)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
de réir: Kahori Miyamoto, et al.
Foilsithe / Cruthaithe: (2022)

Future of Carrier-Free Dry Powder Inhaler Formulations
de réir: Ali Nokhodchi, et al.
Foilsithe / Cruthaithe: (2024)

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
de réir: Xiaoxuan Han, et al.
Foilsithe / Cruthaithe: (2023)

Experimental Evaluation of Dry Powder Inhalers during Inhalation and Exhalation Using a Model of the Human Respiratory System (xPULM™)
de réir: Richard Pasteka, et al.
Foilsithe / Cruthaithe: (2022)

PREPARATION OF ISONIAZID AS DRY POWDER FORMULATIONS FOR INHALATION BY PHYSICAL MIXING AND SPRAY DRYING
de réir: SOMCHAI SAWATDEE, et al.
Foilsithe / Cruthaithe: (2006)

An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation
de réir: Tânia Marante, et al.
Foilsithe / Cruthaithe: (2020)

Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers
de réir: Tongtong Zhang, et al.
Foilsithe / Cruthaithe: (2018)

Physicochemical and Aerosolization Assessment of Inhalable Spray Dried Fluconazole Powder
de réir: Hamed Hamishehkar, et al.
Foilsithe / Cruthaithe: (2018)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
de réir: Imco Sibum, et al.
Foilsithe / Cruthaithe: (2019)

In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters
de réir: Sawittree Sahakijpijarn, et al.
Foilsithe / Cruthaithe: (2021)

Amorphicity and Aerosolization of Soluplus-Based Inhalable Spray Dried Powders
de réir: Bishal Raj Adhikari, et al.
Foilsithe / Cruthaithe: (2022)

Detection of Excipient-Excipient Interaction in Dry Powder Inhaler Formulation Prepared by Spray Drying
de réir: Aiesheh Gholizadeh-Hashjin, et al.
Foilsithe / Cruthaithe: (2024)

Nanocrystal Agglomerates of Curcumin Prepared by Electrospray Drying as an Excipient-Free Dry Powder for Inhalation
de réir: Shahram Emami, et al.
Foilsithe / Cruthaithe: (2024)

Screening of Cyclodextrins in the Processing of Buserelin Dry Powders for Inhalation Prepared by Spray Freeze-Drying
de réir: Mostafa Rostamnezhad, et al.
Foilsithe / Cruthaithe: (2023)

Development of Biodegradable Polycation-Based Inhalable Dry Gene Powders by Spray Freeze Drying
de réir: Tomoyuki Okuda, et al.
Foilsithe / Cruthaithe: (2015)

Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development
de réir: Abhinav Ram Mohan, et al.
Foilsithe / Cruthaithe: (2022)

Case Report: Respiratory paralysis associated with polymyxin B therapy
de réir: Yachan Ning, et al.
Foilsithe / Cruthaithe: (2022)

Moisture-Resistant Co-Spray-Dried Netilmicin with <span style="font-variant: small-caps">l</span>-Leucine as Dry Powder Inhalation for the Treatment of Respiratory Infections
de réir: Yingtong Cui, et al.
Foilsithe / Cruthaithe: (2018)

Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery
de réir: Mehdi Hassanpour Aghdam, et al.
Foilsithe / Cruthaithe: (2016)

Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles
de réir: Jaleh Varshosaz, et al.
Foilsithe / Cruthaithe: (2017)

Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery
de réir: Md Abdur Rashid, et al.
Foilsithe / Cruthaithe: (2019)

Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
de réir: Sawittree Sahakijpijarn, et al.
Foilsithe / Cruthaithe: (2020)